Skip to main content
. 2022 Sep 27;11(12):1578–1591. doi: 10.1002/psp4.12862

FIGURE 4.

FIGURE 4

Model‐predicted SUVr and plasma Aβ42/40 ratio and p‐tau181 following 18 months treatment with lecanemab at 10 mg/kg biweekly or 10 mg/kg monthly. Black dashed line in SUVr plot represents SUVr = 1.17, indicating amyloid negative line. For SUVr, baseline SUVr = 1.38 (median of Study 201) was assumed. Pink solid line and shaded area: predicted median and 95% CI for 10 mg/kg biweekly, blue solid line and shaded area: predicted median and 95% CI for 10 mg/kg monthly. CI, confidence interval; PET, positron emission tomography; SUVr, standard uptake ratio.